Cerus (CERS) Return on Capital Employed Growth (1y) (2012 - 2026)
Cerus (CERS) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.80 Bn | 176.50 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 128.84 Bn | 125.96 Bn | 3.81 Bn | -1,390.00 |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 68.51 Bn | 67.06 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 48.18 Bn | 44.51 Bn | 1.29 Bn | -110.00 |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | 658.00 |
| 7 | GE HealthCare Technologies | 28.16 Bn | 25.88 Bn | 1.98 Bn | -3,185.00 |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn | 125.00 |
| 10 | Cerus | 605.72 Mn | 525.30 Mn | 27.89 Mn | 625.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 625.00 |
| Dec 31, 2025 | 343.00 |
| Sep 30, 2025 | 131.00 |
| Jun 30, 2025 | 275.00 |
| Mar 31, 2025 | 852.00 |
| Dec 31, 2024 | 1,157.00 |
| Sep 30, 2024 | 2,467.00 |
| Jun 30, 2024 | 2,142.00 |
| Mar 31, 2024 | 1,065.00 |
| Dec 31, 2023 | 1,181.00 |
| Sep 30, 2023 | -781.00 |
| Jun 30, 2023 | -862.00 |
| Mar 31, 2023 | -222.00 |
| Dec 31, 2022 | -149.00 |
| Sep 30, 2022 | 1,030.00 |
| Jun 30, 2022 | 1,306.00 |
| Mar 31, 2022 | 975.00 |
| Dec 31, 2021 | 436.00 |
| Mar 31, 2021 | 938.00 |
| Dec 31, 2020 | 2,071.00 |